Your browser doesn't support javascript.
loading
Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system.
Xiang, Dao-Chun; Chen, Wei; Fu, Zhi-Wen; Wu, Xin-Hua; Gao, Ping; Wu, Yue.
Afiliação
  • Xiang DC; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Chen W; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Fu ZW; Department of Pharmacy, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu XH; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Gao P; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Wu Y; Wuhan Union Hospital of China, Huazhong University of Science and Technology, Wuhan, P. R. of China.
Expert Opin Drug Saf ; 22(10): 943-955, 2023.
Article em En | MEDLINE | ID: mdl-37294594

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2023 Tipo de documento: Article